Showing 42,161 - 42,180 results of 112,387 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (fold decrease)) ))', query time: 1.71s Refine Results
  1. 42161

    S1 Data - by George Mrema (19550255)

    Published 2024
    “…During this period, the point prevalence of leprosy declined from 0.32 to 0.25 per 10,000 people, and the new case detection rate decreased from 3.1 to 2.4 per 100,000 people; however, these changes were not statistically significant (p > 0.05). …”
  2. 42162
  3. 42163

    DANGER1A increases neurite outgrowth in response to NGF signaling. by Nikolas Nikolaidis (68300)

    Published 2013
    “…PC12 cells depleted of endogenous D1A using siRNA have decreased neurite outgrowth. …”
  4. 42164
  5. 42165
  6. 42166
  7. 42167

    Immunohistochemical staining in each group. by Yue Yang (52715)

    Published 2017
    “…<p>Increase in the frequency with same amount of treadmill exercise decreased the MIA-induced degradation of COL2A1 in articular cartilage and reduced the expression of MMP-13 and NF-κB p65. …”
  8. 42168

    A visual example of DV-misclassification relationships and the results of the statistical simulations. by Alexander J. Millner (817690)

    Published 2015
    “…The red and green arrows in (A) and (B) represent data points that will be misclassified due to participants inaccurately categorizing their suicidal behavior. …”
  9. 42169
  10. 42170

    Tamoxifen induction at E11.5 causes overproduction of oversized, innervated taste buds in <i>ShhCreER</i><sup><i>T2</i></sup><i>/Shh</i><sup><i>f</i></sup> mutant tongues. by Maha El Shahawy (557888)

    Published 2017
    “…(<b>A,B</b>) <i>In situ</i> hybridization with a riboprobe targeting <i>Shh</i> exon2 (the deleted allele) in E13.5 control (A) and mutant (B) tongues showing severely decreased <i>Shh</i> expression (purple) in the mutant tongue. …”
  11. 42171

    CPA treatment lowered activated caspase 3 and GFAP levels while DPCPX increased activated Caspase 3 and GFAP levels. by Manuel Soliño (5410001)

    Published 2018
    “…F) Quantification of C3a by WB. DPCPX produced a highly significant rise in C3a relative density compared to CTL (1.85±0.5 vs 1.01±0.07; unpaired Student´s t-test; p<0.01; n = 4), **p<0.01.…”
  12. 42172
  13. 42173
  14. 42174
  15. 42175

    Data_Sheet_1_Gut microbiota of preterm infants in the neonatal intensive care unit: a study from a tertiary care center in northern India.docx by Prabavathi Devarajalu (17929847)

    Published 2024
    “…DNA was extracted using a DNeasy Powersoil DNA isolation kit. 16S rRNA gene sequencing targeting the V3–V4 region was performed using the MiSeq platform. …”
  16. 42176

    A comprehensive study of glucose and oxygen gradients in a scaled-down model of recombinant HuGM-CSF production in thermoinduced <i>Escherichia coli</i> fed-batch cultures by Greta I. Reynoso-Cereceda (18501789)

    Published 2024
    “…</p> <p></p><p>Thermoinduced recombinant <i>E. coli</i> grew less in a two-compartment scale-down model.</p><p>Heat-inducible <i>E. coli</i> cultures at a large scale significantly decrease recombinant protein production.…”
  17. 42177
  18. 42178

    Image_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

    Published 2022
    “…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”
  19. 42179

    Image_3_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

    Published 2022
    “…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”
  20. 42180

    Table_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.docx by Yunzhi Zhufeng (10961908)

    Published 2022
    “…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”